Emerging drugs for the treatment of Primary Biliary Cholangitis.
about
The changing faces of cholangitisOld and new treatments for primary biliary cholangitis.Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice.MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
P2860
Emerging drugs for the treatment of Primary Biliary Cholangitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Emerging drugs for the treatment of Primary Biliary Cholangitis.
@en
type
label
Emerging drugs for the treatment of Primary Biliary Cholangitis.
@en
prefLabel
Emerging drugs for the treatment of Primary Biliary Cholangitis.
@en
P2093
P2860
P1476
Emerging drugs for the treatment of Primary Biliary Cholangitis.
@en
P2093
Ahmad H Ali
Elizabeth J Carey
James H Tabibian
Keith D Lindor
P2860
P356
10.1517/14728214.2016.1150999
P407
P577
2016-02-22T00:00:00Z